Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Glutamatergic System Counteracts NMDA Dysfunction in Schizophrenia Models BPC-157s glutamate modulation carries particular promise for treatment-resistant schizophrenia and NMDA receptor hypofunction disorders
In many cases, starting with 250mcg per day is enough to stimulate healing without overstimulating pathways or triggering unwanted reactions
BPC-157 + TB-500 reviews Verified reviews from UK research buyers
In supplement form, its only available on prescription and is usually given by injection under the medical supervision of a GP
For a 1 mg daily dose: Volume = 1 mg / 25 mg/mL = 0.04 mL = 4 units That is a very small draw
US$ 23.50
US$ 23.10
US$ 25.14
US$ 20.98
US$ 20.92
US$ 22.61
